Views & Analysis Frontiers Health 2017 Live Blog - Day One coverage The pharmaphorum team were on site and reporting live with all the key learnings and insights from Frontiers Health 2017.
Partner Content Partner Content What oncologists need from you when launching a new therapy At the end of 2015 there were almost 600 new oncology-related molecules in late-stage development, so it is no surprise that two-years on, the number of therapeutic options in cancer care is growin
Partner Content Partner Content Abbvie and Astrazeneca to present keynote address’ at SMi’s ... Drug Discovery conference 2018
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.